domingo, 28 de abril de 2013

National Guideline Clearinghouse | CADTH therapeutic review recommendations: new oral anticoagulants for the prevention of thromboembolic events in patients with atrial fibrillation.

full-text ►
National Guideline Clearinghouse | CADTH therapeutic review recommendations: new oral anticoagulants for the prevention of thromboembolic events in patients with atrial fibrillation.

National Guideline Clearinghouse (NGC)

April 22, 2013


Guideline Title
CADTH therapeutic review recommendations: new oral anticoagulants for the prevention of thromboembolic events in patients with atrial fibrillation.
 
Bibliographic Source(s)
Canadian Agency for Drugs and Technologies in Health (CADTH). CADTH therapeutic review recommendations: new oral anticoagulants for the prevention of thromboembolic events in patients with atrial fibrillation. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health (CADTH); 2012 Jun. 13 p. [18 references]
 
Guideline Status
This is the current release of the guideline.

No hay comentarios:

Publicar un comentario